About the journal
JAC-Antimicrobial Resistance is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,883 GBP. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Oxford University Press
- ISSN
- 2632-1823
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,883 GBP
- Articles in DOAJ
- 0
- Declared review time
- 16 weeks
- Declared peer-review model
- peer_review
- Official website
- https://academic.oup.com/jacamr
Index listings
- DOAJ · 2020-06-04
- Indexing
- DOAJ
- APC
- 1,883 GBP
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
1839
Last recorded publication year
2026
h-index
46
i10-index
350
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-03
- Added to DOAJ
- 2020-06-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 68%
- ORCID iDs in current deposits
- 52%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- JAC-AMRJournal of antimicrobial chemotherapy-antimicrobial resistance
- Source type
- journal
- NLM unique ID (PubMed)
- 101765283
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Bacterial Identification and Susceptibility Testing
- Bacterial Identification and Susceptibility Testing
Show all subjects (50)
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Nosocomial Infections in ICU
- Nosocomial Infections in ICU
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial Resistance in Staphylococcus
- Pharmaceutical and Antibiotic Environmental Impacts
- Pharmaceutical and Antibiotic Environmental Impacts
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
- Antifungal resistance and susceptibility
- Antifungal resistance and susceptibility
- Sepsis Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
- Infection Control in Healthcare
- Infection Control in Healthcare
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Clostridium difficile and Clostridium perfringens research
- Clostridium difficile and Clostridium perfringens research
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Drug-Induced Adverse Reactions
- Neonatal and Maternal Infections
- Neonatal and Maternal Infections
- Surgical site infection prevention
- Drug-Induced Adverse Reactions
- Surgical site infection prevention
- Bacterial biofilms and quorum sensing
- Bacterial biofilms and quorum sensing
- Infections and bacterial resistance
- Infections and bacterial resistance
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Streptococcal Infections and Treatments
- Streptococcal Infections and Treatments
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Reproductive tract infections research
- Reproductive tract infections research
- Salmonella and Campylobacter epidemiology
- Escherichia coli research studies
Keywords (DOAJ)
- antimicrobial resistance
- drug therapy
- antimicrobial stewardship
- infectious diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ